Alfred J Novak Pasithea Therapeutics Corp. (KTTA) insider trading activity

KTTA Quotes by TradingView

Alfred J Novak is Director of Pasithea Therapeutics Corp.. Currently has a direct ownership of 3,500 shares of KTTA, which is worth approximately $13,160. The most recent transaction as insider was on Jun 13, 2024, when has been sold 2,750 shares (Common Stock) at a price of $5.62 per share, resulting in proceeds of $15,455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.5K
0% 3M change
n/a 12M change
Total Value Held $13,160

Alfred J Novak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2024
BUY
Grant, award, or other acquisition
$15,455 $5.62 p/Share
2,750 Added 44.0%
3,500 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
$4,207 $5.61 p/Share
750 Added 50.0%
750 Common Stock

Also insider at

LIVN
LivaNova PLC Healthcare
Director
AJN

Alfred J Novak

Director
London, X0

Track Institutional and Insider Activities on KTTA

Follow Pasithea Therapeutics Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTTA shares.

Notify only if

Insider Trading

Get notified when an Pasithea Therapeutics Corp. insider buys or sells KTTA shares.

Notify only if

News

Receive news related to Pasithea Therapeutics Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KTTA